TK

Takumi Kawabe

CC Canbas Co.: 15 patents #1 of 18Top 6%
TL Takeda Pharmaceutical Company Limited: 2 patents #562 of 1,531Top 40%
HI Hitachi: 1 patents #17,742 of 28,497Top 65%
TA Takata: 1 patents #316 of 608Top 55%
📍 Numazu, JP: #92 of 856 inventorsTop 15%
Overall (All Time): #227,689 of 4,157,543Top 6%
19
Patents All Time

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDate
12239714 Phosphatidylserine-binding conjugates Takuji Sato, Tatsuya Kibe, Toshiyuki Hibino, Jonathan M. Friedman, Sayaka Yamamoto +1 more 2025-03-04
12209079 IDO/TDO inhibitor Akira Asai, Naohisa Ogo, Daisuke MURAOKA, Osamu Takikawa, Takuji Sato 2025-01-28
11023404 Daisy chain connection system and system control method 2021-06-01
10149887 Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment 2018-12-11
9457757 Interlocking structure, mounting member, and airbag device Shuhei Fujiwara, Keisuke Onohara, Kouhei Nagashima 2016-10-04
9221872 Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations Naoki Mine, Naoya Saito, Keiichi Sakakibara, Takuji Sato 2015-12-29
8415357 Compounds with anti-cancer activity Machiyo Ishigaki, Takuji Sato, Sayaka Yamamoto, Yoko Hasegawa 2013-04-09
8084454 Compounds with anti-cancer activity Machiyo Ishigaki, Takuji Sato, Sayaka Yamamoto, Yoko Hasegawa 2011-12-27
7851592 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents Masashi Suganuma 2010-12-14
7652042 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments Hidetaka Kobayashi 2010-01-26
7629364 Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments Hidetaka Kobayashi 2009-12-08
7479484 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity Hidetaka Kobayashi 2009-01-20
7476657 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments Hidetaka Kobayashi 2009-01-13
7407985 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments Hidetaka Kobayashi 2008-08-05
7358046 Sensitivity test to predict efficacy of anti-cancer therapies Hidetaka Kobayashi 2008-04-15
7125842 Anti-fungal compounds and methods of use Hidetaka Kobayashi 2006-10-24
7030111 Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA damaging treatments Hidetaka Kobayashi 2006-04-18
6995135 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments Hidetaka Kobayashi 2006-02-07
6881575 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents Masashi Suganuma 2005-04-19